Centinel Spine’s Prodisc C Vivo and Prodisc C Nova earned the European Union’s Medical Device Regulation certifications, according to a Sept. 11 news release.
Prodisc C Vivo and C Nova are the only cervical total disc replacement systems with two different MDR-certified devices. They have been used in clinical use internationally since 2009.
“This marks a pivotal moment for Centinel Spine as an organization,” Steve Murray, Centinel Spine’s CEO, said in the release. “Securing MDR certification for the prodisc C Vivo and prodisc C Nova total disc replacement devices has been a complex and demanding process, but it underscores our commitment to delivering safe, high-quality, and clinically-proven products. A fundamental pillar of our strategic vision is to improve the lives of as many patients as possible worldwide by expanding access to prodisc technologies.”
